J. Kugler

发表

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

P. Novotny, H. Wieand, C. Loprinzi, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor response and progression‐free survival as potential surrogate endpoints for overall survival in extensive stage small‐cell lung cancer

J. Jett, S. Mandrekar, N. Foster, 2011, Cancer.

A placebo‐controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome

P. Novotny, J. Sloan, C. Loprinzi, 2007, Cancer.

Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

Daniel G Haller, P. Catalano, J. Berlin, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.

E. Perez, J. Ingle, J. Kugler, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized Phase II Study of Daily Versus Continuous-Infusion Schedules of Topotecan in the Treatment of Extensive-Stage Small Cell Lung Cancers

J. Sloan, R. Marks, J. Kugler, 2003, American journal of clinical oncology.

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

J. Sloan, C. Loprinzi, J. Kugler, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

P. Novotny, J. Sloan, C. Loprinzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.

A. Benson, J. Kugler, J. Robertson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.

E. Perez, J. Ingle, J. Krook, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer.

J. Kugler, H. Pitot, P. Burch, 1997, International journal of radiation oncology, biology, physics.

Phase II trials of 5‐fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma

J. Kugler, R. Morton, J. Rubin, 1996, Cancer.

Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5.

C. Loprinzi, J. Kugler, K. Rowland, 2010 .

Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group

N. Foster, J. Kugler, S. Alberts, 2005, Supportive Care in Cancer.

PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.

P. Schaefer, N. Foster, J. Kugler, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase II trial of suramin monthly × 3 for hormone‐refractory prostate carcinoma

Walter M Stadler, Mark J Ratain, Nicholas J Vogelzang, 2004, Cancer.

Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.

D. S. Gordon, J. Kugler, R. Silver, 1995, The cancer journal from Scientific American.

Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation.

R. Kerber, D. Ferguson, M. Marcus, 1986, Cancer treatment reports.

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

J. Kugler, R. Bukowski, S. Jones, 1993, Journal of the National Cancer Institute.

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.

J. Jett, R. Goldberg, C. Loprinzi, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.

P. Novotny, J. Sloan, C. Loprinzi, 1999, The New England journal of medicine.

Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.

T. Cascino, J. Sloan, C. Loprinzi, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens.

J. Edmonson, G. Malkasian, J. Laurie, 1989, Journal of the National Cancer Institute.

Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinoma.

R. Goldberg, J. Kugler, R. Levitt, 1994, Gynecologic oncology.

Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.

J. Kugler, K. Rowland, V. Suman, 2006, Gynecologic oncology.

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.

R. Schilsky, E. Vokes, J. Kugler, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double-blind NCCTG trial N04C7

P. Novotny, J. Sloan, C. Loprinzi, 2008 .

Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer: A North Central Cancer Treatment Group Study

E. Perez, J. Jett, S. Hillman, 2010, American journal of clinical oncology.

Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.

M. J. Webb, J. Kugler, H. Wieand, 1995, Gynecologic oncology.

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia: A phase II study from the North Central Cancer Treatment Group

N. Foster, J. Kugler, S. Alberts, 2005 .

Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.

J. Jett, R. Marks, J. Kugler, 1999, American journal of clinical oncology.

Pemetrexed and Gemcitabine for Biliary Tract and Gallbladder Carcinomas: a North Central Cancer Treatment Group (NCCTG) Phase I and II Trial, N9943

N. Foster, J. Kugler, S. Alberts, 2007, Journal of gastrointestinal cancer.

A phase II study of 5‐fluorouracil, leucovorin, and interferon‐α in the treatment of patients with metastatic or recurrent gastric carcinoma

S. Lipsitz, M. Morrisey, A. Benson, 1999, Cancer.

Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants.

J. Armitage, C. Helms, J. Kugler, 1983, The American journal of medicine.

Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.

Thomas K. Schulz, J. Krook, J. Kugler, 2004, Lung cancer.

A phase II study of a combination of pemetrexed (Pem) and gemcitabine (Gem) in patients with metastatic breast cancer (MBC): An NCCTG study.

E. Perez, J. Ingle, J. Kugler, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A clinical trial of biochemical modulation of 5‐fluorouracil with N‐phosphonoacetyl‐L‐aspartate and thymidine in advanced gastric and anaplastic colorectal cancer

R. Goldberg, J. Laurie, J. Krook, 1990, Cancer.

Measurable or assessable disease in lung cancer trials: does it matter?

J. Jett, R. Goldberg, J. Krook, 1994, Journal of Clinical Oncology.

N0337: Phase II study of capecitabine in combination with vinorelbine and trastuzumab for the first or second treatment of HER2+ metastatic breast cancer.

E. Perez, J. Kugler, P. Flynn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52

E. Perez, J. Donohue, M. Goetz, 2006, Breast Cancer Research and Treatment.

Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study.

J. Krook, J. Kugler, S. Nair, 1998, American journal of clinical oncology.

NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: Phase II results

N. Foster, J. Kugler, S. Alberts, 2007 .

A randomized phase II trial of Interleukin-2 in combination with four different doses of bryostatin in patients with renal cell carcinoma.

E. Vokes, J. Kugler, W. Stadler, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).

S. Hillman, R. Marks, J. Kugler, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

C. Loprinzi, J. Kugler, K. Rowland, 2011, Supportive Care in Cancer.

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma

E. Vokes, J. Kugler, W. Stadler, 2006, Investigational New Drugs.

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

E. Perez, J. Jett, S. Mandrekar, 2008, Lung cancer.

THE USE OF PARTIALLY MATCHED, UNRELATED DONORS IN CLINICAL BONE MARROW TRANSPLANTATION

J. Armitage, J. Kugler, L. Klassen, 1985, Transplantation.

A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas

B. Scheithauer, T. Cascino, J. Buckner, 2000, Investigational New Drugs.

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.

J. Kugler, R. Morton, D. Ahmann, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

E. Shaw, J. Jett, C. Loprinzi, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Trial of Oral Trimethylcolchicinic Acid in Patients with Hormone Refractory Prostate Cancer

M. Ratain, E. Vokes, J. Kugler, 1999 .

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

Caterina Giannini, Jan C Buckner, Paul D Brown, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.

P. Novotny, J. Sloan, C. Loprinzi, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective, randomized evaluation of intensive‐course 5‐fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

H. Wieand, R. Beart, J. Krook, 1991, Cancer.

Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.

D. Sargent, J. Krook, J. Kugler, 2006, Clinical colorectal cancer.

Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer

R. Schilsky, E. Vokes, J. Kugler, 1998, Investigational New Drugs.

Utility of flow cytometry immunophenotyping for the diagnosis and classification of lymphoma in community hospital clinical needle aspiration/biopsies.

J. Kugler, J. Knost, P. Fishkin, 2000, Archives of pathology & laboratory medicine.

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

Debra L Barton, T. Rummans, P. Novotny, 2000, The Lancet.

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

M. Jiroutek, D. Cella, D. Fairclough, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

David Cella, J. Manola, D. Cella, 2002, Journal of the National Cancer Institute.

Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.

E. Perez, E. Shaw, J. Sloan, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pure red cell aplasia associated with administration of sustained-release procainamide.

J. Kugler, S. Krantz, L. Giannone, 1987, Archives of internal medicine.

Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.

M. Ratain, E. Vokes, J. Kugler, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.

D. Sargent, P. Johnston, R. Goldberg, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use

J. Kugler, D. Kao, H. E. Kohrt, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Randomized, Placebo-Controlled, Phase III Surgical Adjuvant Clinical Trial of Megestrol Acetate (Megace) in Selected Patients With Malignant Melanoma

R. Fitzgibbons, J. Buckner, J. Krook, 2002, American journal of clinical oncology.

Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.

B. Scheithauer, J. O'fallon, T. Cascino, 1995, Journal of neurosurgery.

A north central cancer treatment group Phase II trial of 9‐aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

D. Sargent, R. Goldberg, J. Krook, 2000, Cancer.

Randomized C omparison o f M egestrol A cetate V ersus Dexamethasone V ersus F luoxymesterone f or t he Treatment o f C ancer A norexia/Cachexi a

P. Novotny, J. Sloan, C. Loprinzi, 1999 .

Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.

D. Sargent, J. Sloan, R. Goldberg, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy a nd Q uality-of-Life D ata A re R elated i n a P hase I I Trial o f O ral C hemotherapy i n P reviously U ntreated P atients With M etastatic C olorectal C arcinoma

D. Sargent, J. Sloan, R. Goldberg, 2002 .

Marrow transplantation for stable-phase chronic granulocytic leukemia.

J. Kugler, L. Klassen, J. Armitage, 1984, Experimental hematology.

A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index.

J. Sloan, P. Novotny, C. Loprinzi, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Coumarin-induced hepatotoxicity.

J. Sloan, C. Loprinzi, J. Kugler, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)

P. Novotny, J. Sloan, C. Loprinzi, 2011, Supportive Care in Cancer.

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive‐stage small cell lung carcinoma

J. Jett, S. Hillman, R. Marks, 2003, Cancer.

Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck

J. Kugler, S. Nair, V. Suman, 2002, Cancer.

Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group

J. Jett, J. Krook, J. Kugler, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.

J. Jett, R. Marks, J. Kugler, 2002, International journal of radiation oncology, biology, physics.

A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study.

E. Perez, J. Ingle, J. Kugler, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group.

A. Benson, J. Kugler, D. Haller, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study.

S. Cha, D. Sargent, R. Goldberg, 2005, Clinical colorectal cancer.

Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.

D. Sargent, J. Kugler, P. Burch, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.

P. Novotny, C. Loprinzi, J. Kugler, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2367 : Does Zinc Sulfate To Prevent Radiation-Induced Taste Alterations (“Dysgeusia”) in Head and Neck Cancer Patients? A North Central Cancer Treatment Group (NCCTG) Placebo-Controlled Trial (N01C4)

J. Sloan, C. Loprinzi, J. Kugler, 2006 .

CI-980 in Advanced Melanoma and Hormone Refractory Prostate Cancer

J. Sosman, E. Vokes, J. Kugler, 2000, Investigational New Drugs.

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

P. Novotny, J. Sloan, C. Loprinzi, 2009 .

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

J. Kugler, R. Bukowski, S. Jones, 1993, Journal of the National Cancer Institute.

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: A randomized, phase III trial

T. Therneau, J. Earle, J. Jett, 1991 .

O-68 Long term results of a phase III trial comparing once a day radiotherapy (qd RT) or twice a day radiotherapy (bid RT) in limited stage small cell lung cancer (LSCLC)

J. Jett, S. Hillman, J. Krook, 2003 .

Pemetrexed and Gemcitabine for Biliary Tract and Gallbladder Carcinomas: a North Central Cancer Treatment Group (NCCTG) Phase I and II Trial, N9943

N. Foster, J. Kugler, S. Alberts, 2007, Journal of gastrointestinal cancer.

Efficacy and toxicity of cetuximab (C225) plus mFOLOFX6 in patients (pts) with nonoptimally resectable, colorectal metastases (MCRC) confined to the liver

J. Donohue, J. Kugler, S. Alberts, 2008 .

Should attribution be considered when interpreting adverse event data: A North Central Cancer Treatment Group (NCCTG) evaluation of a phase III placebo controlled trial.

E. Perez, J. Buckner, D. Sargent, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.

John D. Roberts, C. Bloomfield, N. Christakis, 2005, Journal of the National Cancer Institute.